Join to view full profile
1237 Harding PlSte 3100Charlotte, NC 28204
Phone+1 704-373-0212
Dr. Rinaldi is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- My current focus includes interventional cardiology and structural heart intervention including TAVR, TMVr, TMVR, LAA closure, TTVr, TTVR. I serve a Director of the Structural Heart Program for the Sanger Heart and Vascular Institute in Charlotte, NC. My interests also include clinical research, clinical trials, and education.
Education & Training
Boston Medical Center - BrightonVascular Medicine and Peripheral Vascular Intervention, 2001 - 2002
Beth Israel Deaconess Medical CenterFellowship, Interventional Cardiology, 2000 - 2002- Beth Israel Deaconess Medical CenterFellowship, Cardiovascular Disease, 1997 - 2000
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1994 - 1997
Weill Cornell MedicineClass of 1994
Certifications & Licensure
GA State Medical License 2021 - 2028
NC State Medical License 2002 - 2027
SC State Medical License 2007 - 2027
MA State Medical License 1996 - 2003
American Board of Internal Medicine Cardiovascular Disease- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Fellow SCAI
- CMS Meaningful Use Stage 2 Certification Cerner Patient Portal and Powerchart, Cerner Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification P2 Sentinel, Cerner Corporation, 2012, 2014, 2016-2017
Clinical Trials
- Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
- Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).
- Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial) and COAPT CAS
Publications & Presentations
PubMed
- 2 citationsReal-World Outcomes of Dedicated Leaflet Modification for Bioprosthetic Valve-In-Valve TAVR: A 150-Patient Commercial Experience.Raj R Makkar, Aakriti Gupta, Ignacio Inglessis, Curtiss T Stinis, Pradeep K Yadav
JACC. Cardiovascular Interventions. 2026-09-28 - Age and Procedural Timing for Asymptomatic Severe Aortic Stenosis: Analysis From the EARLY TAVR Trial.Kashish Goel, Brian R Lindman, Allan Schwartz, David J Cohen, Gennaro Giustino
Circulation. Cardiovascular Interventions. 2026-08-01 - 26 citationsTricuspid valve replacement outcomes by baseline tricuspid regurgitation severity: the TRISCEND II trial.Philipp Lurz, Rebecca T Hahn, Susheel Kodali, Raj Makkar, Rahul P Sharma
European Heart Journal. 2026-05-05
Press Mentions
Cardiologist Praises Updated Design of New TMVR System After Historic Interventional ProcedureAugust 26th, 2022- Alternative to Open Heart Surgery Debuts in the CarolinasJune 10th, 2024
- Atrium Health Sanger Heart & Vascular Institute Performs Landmark Heart Valve SurgeryJune 11th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
